Page 228 - ASHG 2013 Program Guide

POSTER SESSIONS
  215
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
2514
W A review of the Welsh breast cancer screening
program for women with a family history of breast
cancer at a moderately increased risk.
S.L. M. Nisbet,
L. Murray, K. Pegington, M. T. Rogers, K. Gower-Thomas,
A. J. Murray.
2515
W Documenting family history of cancer and
referral for genetic counseling and testing in screening
families at risk of hereditary breast or colorectal
cancer.
I. Shapira, K. Cheng, V. John, K. Sultan, R.
Sharma, D. Gokalp Yasar, N. Nyatanga, N. Eisler, J. Cho,
E. Taioli.
2516
W Needs assessment of individuals with 22q11.2
deletion syndrome transitioning from pediatric to
adult health care settings.
W. L. A. Fung, E. Leung, A. S.
Bassett.
2517
W The DSD-Translational Research Network,
a national research and clinical network to improve
health for people with disorders of sex development.
E. Delot, D. E. Sandberg, E. Vilain.
2518
W Whole genome sequencing vs. family history:
Physician perceptions of clinical utility.
J. L. Vassy, R.
C. Green, J. Krier, D. Lautenbach, K. D. Christensen, M.
A. Giovanni, M. F. Murray, A. L. McGuire, for The MedSeq
Project.
2519
W Conceptualizing family history taking in clinical
pediatric practice.
L. Tessier, B. K. Potter, J. Brehaut,
P. Chakraborty, J. C. Caroll, J. Allanson, J. Little, D.
Castle, B. J. Wilson, CIHR Emerging Team in Genomics in
Screening.
2520
W Genetic counsellors’ preferences for
preimplantation genetic diagnosis: Designing a
discrete choice experiment.
E. Goh, W. Ungar, D.
Marshall, F. Miller.
2521
W Identification and characterization of genetic
services in Peru.
M. R. Cornejo-Olivas, M. R. Velit-
Salazar, T. Avalos-Cruz, MD, M. M. Duenas-Roque, MD,
M. Inca-Martinez, A. P. Mora-Alferez, MD, S. M. Siccha-
Arancibia, M. Brunner-Sciarra, MS, PhD, P. Mazzetti, MD,
MBA, M. I. De Michelena, MD, PhD, C. Matos-Miranda,
MD, MsC.
Clinical Genetic Testing
2522
W Diagnostic application of targeted
resequencing for familial nonsyndromic hearing loss.
B. Choi, G. Park, J. Kim, A. R. Kim, B. J. Kim, T. Park,
S. Oh, K. Han, W. Park.
2523
T Automating clinical exome analysis.
M. N.
Bainbridge, E. B. Venner, C. Eng, Y. Yang, R. A. Gibbs.
2524
F Design and validation of next-generation
sequencing reference standards for oncology.
J.
Goodall, C. Lowe, C. Thorne, A. Mulligan, J. Frampton,
B. Burke, K. Schmitt, P. Morrill.
Health Services Research
2501
W Using the Cleveland Clinic Score to predict for
germline
PTEN
mutations in the analytical algorithm
of Cowden syndrome: A cost effectiveness study.
J. Ngeow, J. Mester, C. Eng.
2502
W Genetic tests evolution in the genomic era:
Is cost evaluation a relevant factor in health care
planning?
D. Coviello, C. Lanza, A. Seri, M. Parodi,
P. Casale, A. Fabbri, S. Casati, M. Esposto.
2503
W Innovation in genomic medicine to realize the
bioeconomy in Mexico.
S. March, F. Valdez-Ortega, G.
Soberon, J. Frenk, G. Jimenez-Sanchez.
2504
W Awareness of genetic breast cancer epidemic
in Iceland.
V. Stefansdottir, J. J. Jonsson, O.T.
Johannsson.
2505
W My46: A genetic counseling extender.
K. M.
Dent, S. M. Jamal, J. H. Yu, H. K. Tabor, M. J. Bamshad.
2506
W Engaging health professionals in evaluations of
emerging genomic technologies.
C. Catley, J. Little, S.
Nicholl, H. Etchegary, J. C. Carroll, D. Castle, L. Lemyre, B.
K. Potter, B. J. Wilson, CIHR Emerging Team in Genomics
in Screening.
2507
W Uptake of a web-based patient-entered
cancer family history collection tool.
M. Doerr,
S. Griffith, C. Eng.
2508
W Perspectives on universal screening for Lynch
syndrome in a managed care setting.
J. V. Davis, T.
Kauffman, J. Reiss, C. McGinley, K. Arnold, M. Gilmore, K.
A. B. Goddard.
2509
W The awareness and need of genetic counseling
service in Korea.
H. J. Kim.
2510
W Modeling of downstream counseling
impact of ACMG recommendations for reporting of
incidental findings in clinical exome and genom
sequencing.
L. Burnett, L. C. Ding, D. Chesher, R. Lew,
A. Proos.
2511
W Factors that drive pediatric medical
management following chromosome microarray
analysis.
R. Hayeems, N. Hoang, S. Chenier, J.
Stavropoulos, S. Pu, S. Wodak, R. Babul-Hirji, J. Davies,
L. Velsher, J. Aw, R. Weksberg, C. Shuman.
2512
W The NINDS Repository Biomarkers Discovery
Collection: A public resource of biomaterials for
neurodegenerative disease research.
C. Tarn, M. Self,
K. Gwinn, M. Sutherland, C. Pérez, W. Muhammad, G.
Balaburski, M. Frasier, L. Vincent, R. Corriveau.
2513
W Measuring treatment preferences of parents
of children with Duchenne muscular dystrophy using
best-worst scaling.
H. L. Peay, I. Hollin, H. Sheffer, J. F.
P. Bridges.